A discussion of The Playbook, from DiMe Society, Digital Clinical Measures Introducing the essential industry guide for successfully developing & deploying digital clinical measures across clinical research, clinical care, and public health <a href="https://playbook.dimesociety.org">https://playbook.dimesociety.org</a> More on Andy (Andrea) Coravos here: <a href="http://www.andreacoravos.com">http://www.andreacoravos.com</a> More on Jen (Jennifer) Goldsack here: <a href="https://en.wikipedia.org/wiki/Jennifer_Goldsack">https://en.wikipedia.org/wiki/Jennifer_Goldsack</a> More on DiMe Society here: <a href="https://www.dimesociety.org">https://www.dimesociety.org</a>

A discussion of The Playbook, from DiMe Society, Digital Clinical Measures Introducing the essential industry guide for successfully developing & deploying digital clinical measures across clinical research, clinical care, and public health https://playbook.dimesociety.org More on Andy (Andrea) Coravos here: http://www.andreacoravos.com More on Jen (Jennifer) Goldsack here: https://en.wikipedia.org/wiki/Jennifer_Goldsack More on DiMe Society here: https://www.dimesociety.org

A discussion of The Playbook, from DiMe Society, Digital Clinical Measures&nbsp;Introducing the essential industry guide for successfully developing &amp; deploying digital clinical measures across clinical research, clinical care, and public health&nbsp;<a href="https://playbook.dimesociety.org" rel="noopener noreferrer">https://playbook.dimesociety.org</a>&nbsp;More on Andy (Andrea) Coravos here: <a href="http://www.andreacoravos.com" rel="noopener noreferrer">http://www.andreacoravos.com</a>&nbsp;More on Jen (Jennifer) Goldsack here: <a href="https://en.wikipedia.org/wiki/Jennifer_Goldsack" rel="noopener noreferrer">https://en.wikipedia.org/wiki/Jennifer_Goldsack</a>&nbsp;More on DiMe Society here: <a href="https://www.dimesociety.org" rel="noopener noreferrer">https://www.dimesociety.org</a>

IDEA Collider | Andy Coravos and Jen Goldsack, The DiMe Society Playbook

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.

Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.

Questions We Explore

* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?


🎧 Listen and subscribe on all major platforms.

Business

Science

Marketing

Management

Life Sciences

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking. Questions We Explore * What is asymmetric learning, and how does it fuel pharma innovation? * Why do some organizations outpace others—and what can we learn from them? * How can we overcome barriers to meaningful progress in healthcare? * What’s broken in traditional innovation models—and how do we fix it? 🎧 Listen and subscribe on all major platforms.

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.

Each episode dives into how organizations can make smarter decisions earlier, reimagine R&amp;D, and unlock competitive advantage through differentiated thinking.

Questions We Explore

* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?


🎧 Listen and subscribe on all major platforms.

Share IDEA Collider | Andy Coravos and Jen Goldsack, The DiMe Society Playbook

Sign up to save your podcasts

IDEA Collider | Andy Coravos and Jen Goldsack, The DiMe Society Playbook

IDEA Collider | Andy Coravos and Jen Goldsack, The DiMe Society Playbook

More shows like IDEA Collider: Innovation & Asymmetric Learning in Pharma

Odd Lots

The Daily

The Readout Loud

FT News Briefing

The Journal.

BioCentury This Week

People I (Mostly) Admire

The Ezra Klein Show

Biotech Hangout

The Rest Is Politics

The Top Line

The Rest Is Politics: US

The BioCentury Show

The Economics Show

Cures & Capital